FDA approvals on the horizon? no need for CR especially with 2.6mill R&D refund due this quarter. and not to mention increased sales. and perhaps sti and superbug detection kits get approvals soon on home soil. not to mention the small amount of shares on issue for retails purchase, the other 80+% held by top 20.... one of my favourite companies. not exactly sure how much top20 hold now. would be interesting to know.
Ann: Appendix 4C - quarterly, page-6
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
69.0¢ |
Change
0.010(1.47%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 69.0¢ | 68.5¢ | $145.8K | 211.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2851 | 68.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 10137 | 1 |
View Market Depth
| Last trade - 15.46pm 28/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
